Who Owns Psyence Biomedical Stock?
NASDAQ: PBMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:55 PM ET
Ownership breakdown
- Held by institutions
- 13.24%
- Held by insiders
- 2.97%
- Institutional holders
- 9
- Institutions 13.2%
- Insiders 3.0%
- Public and other 83.8%
Who owns Psyence Biomedical stock?
Institutional investors own about 13.2% of Psyence Biomedical's shares, spread across 9 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.97% of PBM.
The largest institutional holders are Parallel Advisors, LLC (3.97%), AdvisorShares Investments, LLC (3.20%) and Morgan Stanley (0.99%). Together, the top 8 institutions control 9.7% of shares outstanding. In their latest filings, 7 of the top 8 institutions increased their PBM positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PBM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Parallel Advisors, LLC | 151.25K | 3.97% | 0.0% |
| AdvisorShares Investments, LLC | 122.18K | 3.20% | +100.0% |
| Morgan Stanley | 37.80K | 0.99% | +100.0% |
| Jane Street Group, LLC | 30.43K | 0.80% | +100.0% |
| Xtx Topco Ltd | 15.09K | 0.40% | +100.0% |
| Citadel Advisors Llc | 11.69K | 0.31% | +100.0% |
| UBS Group AG | 60 | 0.00% | +100.0% |
| Caitlin John, LLC | 35 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PBM
| Fund | Shares | % Held |
|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 258.54K | 6.78% |
Frequently asked questions
Who is the largest shareholder of Psyence Biomedical?
Parallel Advisors, LLC is the largest institutional shareholder of PBM, owning 3.97% of shares outstanding (151.25K shares) as of its latest 13F filing.
What percentage of Psyence Biomedical is owned by institutions?
Institutions own about 13.2% of PBM shares and 13.6% of the public float.
How much of Psyence Biomedical do insiders own?
Insiders, such as officers and directors, own about 2.97% of PBM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.